Skip to main content
Log in

Apparent diffusion coefficient value of hepatic fibrosis and inflammation in children with chronic hepatitis

  • Paediatric Radiology
  • Published:
La radiologia medica Aims and scope Submit manuscript

Abstract

Purpose

This study was done to prospectively evaluate the usefulness of apparent diffusion coefficient (ADC) in the diagnosis and grading of hepatic fibrosis and inflammation in children with chronic hepatitis.

Materials and methods

Institutional Review Board approval was obtained. This prospective study was carried out on 50 children with chronic hepatitis (mean age 8.3 ± 3.2 years; 33 boys and 17 girls) and 20 age- and sex-matched healthy control children. The children underwent diffusion-weighted magnetic resonance imaging of the liver. The ADC value of the liver was calculated. The hepatic fibrosis stages (F1–F6) and necroinflammatory activity grades (A1–A4) were calculated. The ADC values of different stages of hepatic fibrosis and grades of necroinflammatory activity were calculated.

Results

The mean ADC value of the liver parenchyma was 1.53 ± 0.17 × 10−3 mm2/s in children with chronic hepatitis and 1.74 ± 0.16 × 10−3 mm2/s in controls. The ADC value was significantly lower in children with hepatic fibrosis compared to controls (p = 0.001). There was a significant difference (p = 0.001) in ADC between mild (F1–F3) and advanced (F4–F6) stages of fibrosis. There was a significant difference (p = 0.004) in ADC between mild (A1–A2) and advanced (A3–A4) grades of necroinflammation. The cut-off ADC values used to differentiate mild from advanced fibrosis and necroinflammation were 1.62 and 1.64 mm2/s with an area under the curve of 0.898 and 0.807, respectively. The ADC value negatively correlated with stages of hepatic fibrosis (r = −0.799, p = 0.001) and necroinflammatory activity grade (r = −0.468, p = 0.001).

Conclusions

We conclude that ADC value is an effective noninvasive parameter for the diagnosis and grading of hepatic fibrosis and inflammation in children with chronic hepatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Yoshioka K, Hashimoto S (2012) Can non-invasive assessment of liver fibrosis replace liver biopsy? Hepatol Res 42:233–240

    Article  PubMed  Google Scholar 

  2. Martínez S, Crespo G, Navasa M et al (2011) Noninvasive assessment of liver fibrosis. Hepatology 53:325–335

    Article  PubMed  Google Scholar 

  3. Castera L (2011) Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatol Int 5:625–634

    Article  PubMed Central  PubMed  Google Scholar 

  4. Kim SU, Han KH, Ahn SH (2011) Non-invasive assessment of liver fibrosis: the gap between ideal and real. J Gastroenterol Hepatol 26:937–939

    Article  PubMed  Google Scholar 

  5. Germani G, Hytiroglou P, Fotiadu A et al (2011) Assessment of fibrosis and cirrhosis in liver biopsies: an update. Semin Liver Dis 31:82–90

    Article  PubMed  Google Scholar 

  6. Goodman ZD (2007) Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 47:598–607

    Article  PubMed  Google Scholar 

  7. Chou R, Wasson N (2013) Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med 158:807–820

    Article  PubMed  Google Scholar 

  8. Fiorini E, Cipriano V, De Molo C et al (2012) Real-time elastography as a noninvasive technique for quantification of fibrosis in patients with chronic viral liver disease: preliminary findings. J Ultrasound 15:220–225

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Yap WW, Kirke R, Yoshida EM et al (2013) Non-invasive assessment of liver fibrosis using ARFI with pathological correlation, a prospective study. Ann Hepatol 12:608–615

    PubMed  Google Scholar 

  10. Aguirre D, Behling C, Alpert E et al (2006) Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 239:425–437

    Article  PubMed  Google Scholar 

  11. Godfrey EM, Patterson AJ, Priest AN et al (2012) A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis. Eur Radiol 22:2790–2797

    Article  PubMed  Google Scholar 

  12. Abdel Razek AA, Gaballa G, Elhawarey G et al (2009) Characterization of pediatric head and neck masses with diffusion weighted MR imaging. Eur Radiol 19:201–208

    Article  PubMed  Google Scholar 

  13. Razek AA (2010) Diffusion-weighted magnetic resonance imaging of head and neck. J Comput Assist Tomogr 34:808–815

    Article  PubMed  Google Scholar 

  14. Tosun M, Inan N, Sarisoy H et al (2013) Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation. Eur J Radiol 82:203–207

    Article  PubMed  Google Scholar 

  15. Kovač JD, Daković M, Stanisavljević D et al (2012) Diffusion-weighted MRI versus transient elastography in quantification of liver fibrosis in patients with chronic cholestatic liver diseases. Eur J Radiol 81:2500–2506

    Article  PubMed  Google Scholar 

  16. Pasquinelli F, Belli G, Mazzoni LN et al (2012) MR-diffusion imaging in assessing chronic liver diseases: does a clinical role exist? Radiol Med 117:242–253

    Article  CAS  PubMed  Google Scholar 

  17. Wang Y, Ganger DR, Levitsky J et al (2011) Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 196:553–561

    Article  PubMed Central  PubMed  Google Scholar 

  18. Watanabe H, Kanematsu M, Goshima S et al (2011) Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging–preliminary observations. Radiology 259:142–150

    Article  PubMed  Google Scholar 

  19. Bonekamp S, Torbenson MS, Kamel IR (2011) Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis. J Clin Gastroenterol 45:885–892

    Article  PubMed  Google Scholar 

  20. Do R, Chandanara H, Felker E et al (2010) Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR Am J Roentgenol 195:671–676

    Article  PubMed  Google Scholar 

  21. Sandrasegaran K, Akisik F, Lin C et al (2009) Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 193:1556–1560

    Article  PubMed  Google Scholar 

  22. Taouli B, Tolia AJ, Losada M et al (2007) Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 189:799–806

    Article  PubMed  Google Scholar 

  23. Lewin M, Poujol-Robert A, Boelle PY et al (2007) Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 46:658–665

    Article  CAS  PubMed  Google Scholar 

  24. Koinuma M, Ohashi I, Hanafusa K et al (2005) Apparent diffusion coefficient measurement with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Mag Reson Imaging 22:80–85

    Article  Google Scholar 

  25. Bakan A, Inci E, Bakan S et al (2012) Utility of diffusion-weighted imaging in the evaluation of liver fibrosis. Eur Radiol 22:682–687

    Article  PubMed  Google Scholar 

  26. Taouli B, Chouli M, Martin A et al (2008) Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 28:89–95

    Article  PubMed  Google Scholar 

  27. Fujimoto K, Tonan T, Azuma S et al (2011) Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade. Radiology 258:739–748

    Article  PubMed  Google Scholar 

  28. Soylu A, Kılıçkesmez O, Poturoğlu S et al (2010) Utility of diffusion-weighted MRI for assessing liver fibrosis in patients with chronic active hepatitis. Diagn Interv Radiol 16:204–208

    PubMed  Google Scholar 

  29. Razek AA, Abdalla A, Omran E et al (2011) Diagnosis and quantification of hepatic fibrosis in children with diffusion weighted MR imaging. Eur J Radiol 78:129–134

    Article  PubMed  Google Scholar 

  30. Le Bihan D (2013) Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure. Radiology 268:318–322

    Article  PubMed  Google Scholar 

  31. Razek AA (2012) Diffusion magnetic resonance imaging of the chest tumors. Cancer Imaging 12:452–463

    Article  PubMed Central  PubMed  Google Scholar 

  32. Ishak K, Baptista A, Bianchi L et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699

    Article  CAS  PubMed  Google Scholar 

  33. Knodell RG, Ishak KG, Black WC et al (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435

    Article  CAS  PubMed  Google Scholar 

  34. Goldschmidt I, Baumann U (2012) Hepatic fibrosis in paediatric liver disease. Clin Res Hepatol Gastroenterol 36:268–270

    Article  PubMed  Google Scholar 

  35. Pariente D, Franchi-Abella S (2010) Paediatric chronic liver diseases: how to investigate and follow up? Role of imaging in the diagnosis of fibrosis-good comprehensive overview on available imaging modalities. Pediatr Radiol 40:906–919

    Article  PubMed  Google Scholar 

  36. El-Shabrawi MH, Mohsen NA, Sherif MM et al (2010) Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest. Eur J Gastroenterol Hepatol 22:945–946

    Google Scholar 

  37. Marginean CO, Marginean C (2012) Elastographic assessment of liver fibrosis in children: a prospective single center experience. Eur J Radiol 81:e870–e874

    Article  PubMed  Google Scholar 

  38. Hanquinet S, Rougemont AL, Courvoisier D et al (2013) Acoustic radiation force impulse (ARFI) elastography for the noninvasive diagnosis of liver fibrosis in children. Pediatr Radiol 43:545–551

    Article  PubMed  Google Scholar 

  39. Binkovitz LA, El-Youssef M, Glaser KJ et al (2012) Pediatric MR elastography of hepatic fibrosis: principles, technique and early clinical experience. Pediatr Radiol 42:402–409

    Article  PubMed Central  PubMed  Google Scholar 

  40. Razek AA, Elmongy A, Hazem M et al (2011) Idiopathic Parkinson’s disease: effect of LevoDopa on apparent diffusion coefficient value of the brain. Acad Radiol 18:70–73

    Article  PubMed  Google Scholar 

  41. Abdel Razek AA, Abd El-Gaber N, Abdalla A et al (2009) Apparent diffusion coefficient value of the brain in patients with Gaucher’s disease type II and type III. Neuroradiology 51:773–779

  42. Abdel Razek AA, Sadek A, Gaballa G (2010) Diffusion-weighed MR of the thyroid gland in Graves’ disease: assessment of disease activity and prediction of outcome. Acad Radiol 17:779–783

    Article  PubMed  Google Scholar 

  43. Anderson S, Barry B, Soto J et al (2012) Quantifying hepatic fibrosis using a biexponential model of diffusion weighted imaging in ex vivo liver specimens. Magn Reson Imaging 30:1475–1482

    Article  PubMed  Google Scholar 

  44. Razek AA, Elkhamary S, Mousa A (2011) Differentiation between benign and malignant orbital tumors at 3-T diffusion MR-imaging. Neuroradiology 53:517–522

    Article  PubMed  Google Scholar 

  45. Abdel Razek AA, Elkhamary S, Al-Mesfer S et al (2012) Correlation of apparent diffusion coefficient at 3 tesla with prognostic parameters of retinoblastoma. AJNR 33:944–948

    Article  CAS  PubMed  Google Scholar 

  46. Culverwell A, Sheridan M, Guthrie J et al (2013) Diffusion-weighted MRI of the liver: interpretative pearls and pitfalls. Clin Radiol 68:406–414

    Article  CAS  PubMed  Google Scholar 

  47. Abdel Razek AA, Kamal E (2013) Nasopharyngeal carcinoma: correlation of apparent diffusion coefficient value with prognostic parameters. Radiol Med 118:534–539

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

Ahmed Abdel Khalek Abdel Razek, Mohamed Khashaba, Ahmed Abdalla, Mohamed bayomy, Tarek Barakat declare no conflict of interest.

Ethical standard

All procedures followed were approved by Institutional Review Board (IRB) and in accordance with the ethical standards of the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from parents of patients and controls for being included in the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmed Abdel Khalek Abdel Razek.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Razek, A.A.K.A., Khashaba, M., Abdalla, A. et al. Apparent diffusion coefficient value of hepatic fibrosis and inflammation in children with chronic hepatitis. Radiol med 119, 903–909 (2014). https://doi.org/10.1007/s11547-014-0408-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11547-014-0408-x

Keywords

Navigation